CWS
LFCR icon

Confluence Wealth Services’s Lifecore Biomedical LFCR Stock Holding History

Confluence Wealth Services’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,745
Closed -$19K – 747
2021
Q4 		$19K Buy
+1,745
New +$16.9K 0.01% 750

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Confluence Wealth Services's LFCR Position: Q1 2022 in Review

Confluence Wealth Services sold out of Lifecore Biomedical (LFCR) in Q1 2022, closing a stake of 1,745 shares — an estimated $19K sold.

Confluence Wealth Services first reported a position in LFCR in Q4 2021 and held it in 1 quarter. The position peaked at $19K in Q4 2021. 97 funds tracked by Wall St. Rank hold LFCR as of Q1 2022.

  • Confluence Wealth Services reported no remaining Lifecore Biomedical position as of Q1 2022 after selling out during the quarter.
  • Confluence Wealth Services sold 1,745 Lifecore Biomedical shares in Q1 2022, an estimated $19K.
  • Confluence Wealth Services first reported a position in Lifecore Biomedical in Q4 2021 and held it in 1 quarter.
  • Confluence Wealth Services's Lifecore Biomedical position peaked at $19K in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2022.

Based on Confluence Wealth Services's 13F filing for Q1 2022, filed 26 Apr 2022.